{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Dental Economist Show","title":"Kyle Welch on Why DSO Operators Are Being Blamed for a Problem They Didn't Create","html":"","width":"100%","height":180,"duration":2444,"description":"Why DSO Operators Are Being Blamed for a Problem They Didn't Create\n\nWhy has the DSO deal market stalled even as demand for dental care remains strong?\nIn this episode of The Dental Economist Show, host Mike Huffaker speaks with Kyle Welch, Associate Professor of Accountancy at the George Washington University School of Business, about the capital-market forces shaping private equity, DSO valuations, and the path to liquidity for dental entrepreneurs.\nKyle explains his central thesis: the current slowdown is not simply an operator-performance issue or a reflection of what is happening in the dental chair. It begins higher up the chain with how private equity is valued, how institutional investors allocate capital, and how rising rates have changed the economics behind acquisitions and exits.\nDrawing on his experience at the Stanford University endowment and his research into private equity reporting, Kyle explores why private-market valuations can appear smoother than public markets, why secondary-market discounts matter, and why the capital that once fueled DSO consolidation has become more constrained.\nThe conversation also examines what comes next. Kyle and Mike discuss the pressure created by extended hold periods, the importance of retaining doctor partners, refinancing and debt restructuring, and why combining platforms and pursuing public-market liquidity may offer a more durable path forward for some dental organizations.\nEpisode chapters\n00:00 The capital-markets problem behind the DSO slowdown\n02:09 Kyle’s path from institutional investing to academia\n03:32 Why private equity’s challenges matter to dentistry\n06:49 The accounting “smoothing” effect in private equity\n12:36 Secondary markets and the gap between reported and market value\n15:13 Why this is a private-equity issue—not just a dental issue\n20:00 Capital constraints, dry powder, and the liquidity freeze\n26:50 The two priorities for DSOs: debt coverage and doctor retention\n33:19 Restructuring debt...","thumbnail_url":"https://img.transistorcdn.com/pXIUMbOEuiksPUbVXasFztN2AhF8jLC1sdhC31mYG5Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85MjE0/ZTlmZjRhZjkwYTM5/ZTFkMzcxOWJjMDU3/ZTc2Yi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}